HUM-MOLGEN events: CHI's HIGH PERFORMANCE COMPUTING

HUM-MOLGEN -> Events -> Meetings and Conferences

September 21, 2001

Cambridge Healthtech Institute, The Marriott La Jolla, California
January 14-16

The success of the drug discovery process is now directly related to a company's computation capabilities. Results and research projects that were unimaginable a few years ago are accessible with today's supercomputers. Industry sources expect the IT life-science market to explode to more than $9 billion by 2003. Major IT companies have made significant investments and formed partnerships, with IBM and Compaq each committing $100 million. Data overload from automation and robust database technology means that companies have an immense amount of data on both drug targets and lead compounds. The downside is that these companies are not equipped in infrastructure or organization to efficiently take full advantage of this gold mine. There is also the question of staff: Do we have the right people? How do we use our existing in-house bioinformatics team? Should we outsource or build our own? What's a fair contract for services, profit sharing, and leasing? How many teraflops is enough? This meeting will seek to cover these issues for biotech, pharma, software, and hardware engineers, for application specialists, and for anyone who envisions the marriage of supercomputers and the life sciences.

Organized by:

Cambridge Healthtech Institute

Invited Speakers:

To be announced

Deadline for Abstracts:

December 7, 2001

Registration:

http://www.chidb.com/2002/hpc/reg.htm

E-mail:

fvargus@healthtech.com

Posted by:

Frederick Vargus